Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Taipei Exchange - Delayed Quote TWD

Bio Preventive Medicine Corp. (6810.TWO)

23.45
-0.05
(-0.21%)
At close: 1:52:53 PM GMT+8

Key Executives

Bio Preventive Medicine Corp.

No.18, Taiyuan Street
6F.-1
Zhubei, 302
Taiwan
https://www.bpmbiotech.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Bio Preventive Medicine Corp, a clinical-staged biotech company, focusing on early detection and prevention of diseases. The company offers solutions in prevention, screening, and monitoring chronic diseases and cancers management. It provides DNlite test, a series of patented and clinically validated non-invasive urine test for diabetic kidney disease management, such as DNlite-IVD103 and DNlite-DN_Score. The company was founded in 2014 and is headquartered in Zhubei, Taiwan.

Corporate Governance

Bio Preventive Medicine Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers